Monophasic vs Biphasic Hyaluronic Acid Fillers: A Buyer’s Guide

When distributors, clinic groups and private-label buyers compare hyaluronic acid (HA) fillers, one of the first technical distinctions they encounter is monophasic versus biphasic. The terms describe how the cross-linked HA gel is processed and structured. They do not, by themselves, tell you that one product is universally better than another.

For a professional buyer, the useful question is not simply “Which type is better?” It is: How does the gel structure relate to rheology, handling, product positioning and the portfolio you want to build?

What is a monophasic dermal filler?

A monophasic HA filler is generally presented as a more homogeneous, continuous gel system. Manufacturing and homogenization steps create a smooth gel phase rather than a suspension of distinct gel particles in a carrier phase.

In commercial product ranges, monophasic technology is often used to create multiple profiles with different levels of softness, support and projection. Those differences can be produced by formulation and processing choices that affect rheological properties such as G′, G″, cohesivity and viscosity.

What is a biphasic dermal filler?

Biphasic fillers are commonly described as cross-linked HA gel particles dispersed in a non-cross-linked or less cross-linked HA phase. Particle size, cross-linking, concentration and processing can all influence the final material behavior.

Because manufacturers use different technologies, the word “biphasic” does not define one single rheological profile. Two biphasic products can behave differently, just as two monophasic products can.

Monophasic vs biphasic: the differences that matter to buyers

1. Gel structure

The most basic distinction is structural. Monophasic systems are typically characterized by a continuous gel structure, while biphasic systems are typically particle-based. This affects how products are described and how a manufacturer builds a range.

2. Rheology

Published research shows that HA fillers can differ substantially in elasticity, viscosity, cohesivity and resistance to deformation. These properties are influenced by more than the monophasic/biphasic label alone. Cross-linking technology, HA concentration, molecular weight and processing conditions also matter.

3. Product positioning

A supplier may offer a softer profile for refined correction, a mid-range profile for additional support and a higher-support profile for projection and contouring. For buyers, this profile architecture is often more useful than choosing a product only because it is called monophasic or biphasic.

4. Portfolio consistency

Distributors and brand owners should evaluate whether the supplier can explain how each SKU fits within the full range. A strong product system should make the differences between profiles easy to understand on technical sheets, packaging and sales materials.

What should a distributor ask a supplier?

• Is the filler monophasic or biphasic, and how is the gel system described?

• What is the HA concentration?

• What rheological data are available, including G′ where applicable?

• What needle gauge is supplied or recommended for the product format?

• What injection plane or product positioning is stated in the technical information?

• Are different profiles built on the same technology platform?

• Are the specifications consistent across product pages, labels, IFUs and COA-related documentation?

Why “monophasic is better” is the wrong buying rule

Clinical and laboratory studies have reported measurable differences between monophasic and biphasic fillers, but results vary by product and study design. A broad category label should therefore not replace product-specific evaluation.

For B2B sourcing, the stronger approach is to compare the complete specification set, manufacturing information, quality documentation and intended market position. That makes it easier to select products that fit your customer base instead of relying on a single technical term.

VITRIONA’s monophasic product system

VITRIONA’s current dermal filler range is built around three monophasic HA profiles: DEFINE, LIFT and SCULPT. The range is organized from balanced to enhanced-support and structural positioning, with 1.1 mL and 10 mL formats available.

If you are comparing product profiles for wholesale, distribution or private label, review the complete VITRIONA dermal filler range or discuss your target market through the product inquiry page.

References

• Rheological Characteristics of Hyaluronic Acid Fillers as Viscoelastic Substances.

• The Rheology of Injectable Hyaluronic Acid Hydrogels Used as Facial Fillers: A Review.

• Monophasic and Biphasic Hyaluronic Acid Fillers: Meta-analysis of Randomized Controlled Trials.

For professional and B2B informational purposes only. Product indications, regulatory status and permitted claims vary by market.